Results 211 to 220 of about 10,538,494 (333)

Assessing the Impact of Crohn's Disease on Foot Health-Related Quality of Life: A Case-Control Study. [PDF]

Int Wound J
Escudero-Prados JM, Cortés-Rodríguez A, Monteiro AJ, Losa-Iglesias ME, Gómez-Salgado J, Becerro-de-Bengoa-Vallejo R, Saavedra-García MA, López-López D, Jiménez-Cebrián AM.   +8 more
europepmc   +1 more source

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

, 1997
S. Targan, S. Hanauer, S. V. van Deventer, L. Mayer, D. Present, T. Braakman, K. DeWoody, T. Schaible, P. Rutgeerts   +8 more
semanticscholar   +1 more source

Pyoderma Gangrenosum: A Retrospective Cohort Study of Comorbidities and Therapies in Over 65,000 Patients in the TriNetX Database

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis associated with systemic inflammatory diseases and malignancy. Although biologic therapies demonstrate efficacy in PG, the extent of their real‐world use remains incompletely characterized.
Rhiannon Grange, Tara Sholji, Marra Aghajani, Cindy Kok, John Frew   +4 more
wiley   +1 more source

Esophageal Crohn's Disease Successfully Treated With Risankizumab. [PDF]

ACG Case Rep J
Hallcox T, Stein D.
europepmc   +1 more source

Nail Disorders in Systemic Conditions

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley   +1 more source

Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial

Durable clinical remission, endoscopic healing, and biomarker normalization are key treatment goals for Crohn's disease. The selective anti-interleukin-23 p19 inhibitor risankizumab has demonstrated efficacy and safety in moderately to severely active ...
Kalabic, Jasmina, Neimark, Ezequiel, Wallace, Kori, Fujii, Toshimitsu, Abreu, Maria T, Torres, Joana, Kligys, Kristina, Rausch, Astrid, Liao, Xiaomei, Gao, Xiang, Song, Alexandra, Panaccione, Remo, Cao, Qian, Irving, Peter M, Axler, Jeffrey, Berg, Sofie, Ferrante, Marc, Zhou, Qing, Feagan, Brian   +18 more
core   +1 more source

Long-Term Follow-Up of Pleuroparenchymal Fibroelastosis Associated With Crohn's Disease. [PDF]

Respirol Case Rep
Suzuki Y, Ikushima H, Ueki Y, Maeda T, Hida K, Yoshida K, Takeuchi C, Urushiyama H, Kawakami M, Mitani A, Fujishiro M, Kage H.   +11 more
europepmc   +1 more source

Crohn's Disease [PDF]

Postgraduate Medical Journal, 1953
openaire   +2 more sources

Knowledge Gaps, Treatment Preferences, and Unmet Clinical Needs Among Patients With Inflammatory Bowel Disease: A Cross‐Sectional Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study utilized a cross‐sectional survey via a structured questionnaire to evaluate disease‐related knowledge, treatment preferences, and unmet needs among 200 adults with confirmed inflammatory bowel disease (IBD) at a tertiary referral center.
Yi‐Chen Wu, Chien‐Ming Chen, Tony Kou, Tai‐Di Chen, Ming‐Jung Meng, Chen‐Wang Chang, Jen‐Wei Chou, Tien‐Yu Huang, Cheng‐Tang Chiu, Yu‐Bin Pan, Puo‐Hsien Le, Ming‐Yao Su   +11 more
wiley   +1 more source

Coping Strategies and Experiences of Patients With Crohn's Disease During the COVID-19 Epidemic: A Descriptive Phenomenology Study. [PDF]

Nurs Open
Chen D, Mei W, Liu Q, Yu Z, Pan T, Zhang A, Kong F, Chen Y.   +7 more
europepmc   +1 more source